
Pfizer going ‘all in’ on obesity drug development, CEO Bourla says
(Reuters) -U.S. drugmaker Pfizer is going “all in” to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. Bourla said the experts were helping Pfizer “make better and more sound decisions,” and the company could start a…